Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolonged azithromycin treatment in moderate to severe chronic rhinosinusitis
2005-004736-51Phase 4Completed
- Sponsor
- Prof V Lund
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic rhinosinusitis (CRS) comparing Sumamed with Placebo (2 arms). Primary endpoint: Treatment duration. Started Feb 2006; status: completed.
02
Drugs
azithromycin
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on 2005-004736-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004736-51.